Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Hauswald, Henrik ^a   Dittmar, Jan Oliver ^a   Habermehl, Daniel ^a   Rieken, Stefan ^a   Sterzing, Florian ^a   Debus, Jürgen ^a   Combs, Stephanie E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain metastases; Irradiation; Malignant melanoma; Radiotherapy; WBRT; Whole brain radiotherapy

Indexed keywords

ADULT; ARTICLE; BRAIN EDEMA; BRAIN METASTASIS; BRAIN RADIATION; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; DIZZINESS; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MEMORY DISORDER; MULTIMODALITY CANCER THERAPY; MULTIPLE BRAIN METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION SICKNESS; RETROSPECTIVE STUDY; SOLITARY HEADACHE; STEREOTACTIC RADIOSURGERY; THERAPY EFFECT; TREATMENT RESPONSE; WALKING DIFFICULTY; WHOLE BRAIN RADIOTHERAPY;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA; MIDDLE AGED; RADIOTHERAPY; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84864456883     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-130     Document Type: Article

References (34)

1. Krebs in Deutschland 2005/2006 Häufigkeiten und Trends. 7. Ausgabe 2010, Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg)., Berlin, Krebs in Deutschland 2005/2006.
2. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978, 42:660-668. 10.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E, 679158.
3. Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978, 135:807-810. 10.1016/0002-9610(78)90171-X, 665907.
4. Bullard DE, Cox EB, Seigler HF. Central nervous system metastases in malignant melanoma. Neurosurgery 1981, 8:26-30. 10.1227/00006123-198101000-00006, 7207769.
5. Budman DR, Camacho E, Wittes RE. The current causes of death in patients with malignant melanoma. Eur J Cancer 1978, 14:327-330.
6. Houghton A, Coit D, Bloomer W, Buzaid A, Chu D, Eisenburgh B, Guitart J, Johnson T, Miller S, Sener S, Tanabe K, Thompson J, Urist M, Walker M. NCCN melanoma practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park) 1998, 12:153-177.
7. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 2004, 22:1293-1300. 10.1200/JCO.2004.08.140, 15051777.
8. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
9. Samlowski WE, Watson GA, Wang M, Rao G, Klimo P, Boucher K, Shrieve DC, Jensen RL. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 2007, 109:1855-1862. 10.1002/cncr.22605, 17351953.
10. Broadbent AM, Hruby G, Tin MM, Jackson M, Firth I. Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiother Oncol 2004, 71:259-265. 10.1016/j.radonc.2004.02.019, 15172140.
11. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43:795-803. 10.1016/S0360-3016(98)00442-8, 10098435.
12. Meier S, Baumert BG, Maier T, Wellis G, Burg G, Seifert B, Dummer R. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie 2004, 27:145-149. 10.1159/000076903, 15138346.
13. Panagiotou IE, Brountzos EN, Kelekis DA, Papathanasiou MA, Bafaloukos DI. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. Neoplasma 2005, 52:150-158.
14. Rate WR, Solin LJ, Turrisi AT. Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression. Int J Radiat Oncol Biol Phys 1988, 15:859-864. 10.1016/0360-3016(88)90118-6, 2460420.
15. Choi KN, Withers HR, Rotman M. Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation. Cancer 1985, 56:1-9. 10.1002/1097-0142(19850701)56:1<1::AID-CNCR2820560102>3.0.CO;2-X, 4005778.
16. Stevens G, Firth I, Coates A. Cerebral metastases from malignant melanoma. Radiother Oncol 1992, 23:185-191. 10.1016/0167-8140(92)90329-S, 1574597.
17. Ellerhorst J, Strom E, Nardone E, McCutcheon I. Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys 2001, 49:93-97. 10.1016/S0360-3016(00)01355-9, 11163501.
18. Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann R-D, Carrie C, Ben Hassel M, Kouri M, Valeinis E, Van Den Berge D, Collette S, Collette L, Mueller R-P. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001. study. J. Clin. Oncol 2011, 29:134-141.
19. Seung SK, Sneed PK, McDermott MW, Shu HK, Leong SP, Chang S, Petti PL, Smith V, Verhey LJ, Wara WM, Phillips TL, Larson DA. Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 1998, 4:103-109.
20. Seung SK, Shu HK, McDermott MW, Sneed PK, Larson DA. Stereotactic radiosurgery for malignant melanoma to the brain. Surg Clin North Am 1996, 76:1399-1411. 10.1016/S0039-6109(05)70522-3, 8977558.
21. Grob JJ, Regis J, Laurans R, Delaunay M, Wolkenstein P, Paul K, Souteyrand P, Koeppel MC, Murraciole X, Perragut JC, Bonerandi JJ. Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie Cutanée. Eur J Cancer 1998, 34:1187-1192. 10.1016/S0959-8049(98)00026-4, 9849477.
22. Herfarth KK, Izwekowa O, Thilmann C, Pirzkall A, Delorme S, Hofmann U, Schadendorf D, Zierhut D, Wannenmacher M, Debus J. Linac-based radiosurgery of cerebral melanoma metastases. Analysis of 122 metastases treated in 64 patients. Strahlenther Onkol 2003, 179:366-371.
23. Ruge MI, Kocher M, Maarouf M, Hamisch C, Treuer H, Voges J, Sturm V. Comparison of stereotactic brachytherapy (125 iodine seeds) with stereotactic radiosurgery (LINAC) for the treatment of singular cerebral metastases. Strahlenther Onkol 2011, 187:7-14. 10.1007/s00066-010-2168-4, 21234527.
24. Buchsbaum JC, Suh JH, Lee S-Y, Chidel MA, Greskovich JF, Barnett GH. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer 2002, 94:2265-2272. 10.1002/cncr.10426, 12001126.
25. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751. 10.1016/S0360-3016(96)00619-0, 9128946.
26. Eigentler TK, Figl A, Krex D, Mohr P, Mauch C, Rass K, Bostroem A, Heese O, Koelbl O, Garbe C, Schadendorf D. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 2011, 117:1697-1703. 10.1002/cncr.25631, 21472716.
27. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010, 77:655-661. 10.1016/j.ijrobp.2009.08.025, 19942357.
28. Rades D, Heisterkamp C, Huttenlocher S, Bohlen G, Dunst J, Haatanen T, Schild SE. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma. Int J Radiat Oncol Biol Phys 2010, 77:537-541. 10.1016/j.ijrobp.2009.05.001, 19733017.
29. Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL. Stereotactic radiosurgery for patients with " radioresistant" brain metastases. Neurosurgery 2002, 51:656-665. discussion 665-667.
30. Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, Kirkwood JM, Tarhini A, Moschos S, Lunsford LD. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J. Neurosurg. 2011, 114:769-779.
31. D'Agostino GR, Autorino R, Pompucci A, De Santis MC, Manfrida S, Di Lella G, Mantini G, Frascino V, Chiesa S, Albanese A, Dinapoli N, Azario L, Fiorentino A, Valentini V, Anile C, Balducci M. Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. Strahlenther Onkol 2011, 187:421-425. 10.1007/s00066-011-2228-4, 21713390.
32. Rades D, Schild SE. Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery?. Strahlenther Onkol 2012, 188(8):702-706. Epub 2012 Mar 16, 10.1007/s00066-012-0093-4, 22418589.
33. Rades D, Kueter JD, Gliemroth J, Veninga T, Pluemer A, Schild SE. Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis. Strahlenther Onkol 2012, 188:143-147. 10.1007/s00066-011-0024-9, 22234538.
34. Rodrigues G, Yartsev S, Tay KY, Pond GR, Lagerwaard F, Bauman G. Phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases. Radiation Oncology (London, England) 2012, 7:42.